Internal Medicine, Rheumatology · Beaumont, TX
NPI
1730474222
Since 2011
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3030 North St Ste 450
Beaumont, TX, 77702
Phone (409) 832-9600
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
1,345 services
Medicare patients, 2024
271
Average age 72
Drug cost, 2024
$2.9M
4,317 prescriptions
Company payments, 2025
$14.69
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarra Musa was code 99214 (office e&m - established), 645 times for 248 patients. In total Sarra Musa billed 1,345 services in 6 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 645 | 248 | $68.55 | $44K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 599 | 239 | $12.26 | $7,344 |
| 99204 Office E&M - New | Facility | 77 | 77 | $88.42 | $6,808 |
| 20610 Joint Injection | Facility | 19 | 15 | $33.52 | $637 |
By year: 2022 $57K for 942 services; 2023 $53K for 760 services; 2024 $59K for 1,345 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarra Musa prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 800 prescriptions and refills. In total Sarra Musa wrote 4,317 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 800 | 1,734 | 218 | $30K |
| Prednisone Generic | 529 | 826 | 207 | $2,595 |
| Gabapentin Generic | 382 | 678 | 105 | $4,179 |
| Methotrexate Methotrexate Sodium | 380 | 671 | 88 | $6,973 |
| Tizanidine Hcl Generic | 270 | 485 | 89 | $1,694 |
| Leflunomide Generic | 215 | 381 | 61 | $10K |
| Enbrel Sureclick Etanercept | 149 | 153 | 23 | $1.0M |
| Sulfasalazine Dr Sulfasalazine | 136 | 225 | 45 | $2,926 |
| Duloxetine Hcl Generic | 102 | 195 | 28 | $1,279 |
| Pregabalin Generic | 91 | 115 | 19 | $855 |
| Folic Acid Generic | 85 | 197 | 23 | $571 |
| Meloxicam Generic | 85 | 159 | 25 | $267 |
| Humira(Cf) Pen Adalimumab | 79 | 79 | 15 | $480K |
| Tramadol Hcl Generic | 73 | 73 | 22 | $401 |
| Celecoxib Generic | 70 | 134 | 24 | $2,933 |
Brand drugs: - claims; generic drugs: 3,693 claims; opioid claims: 89.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarra Musa $14.69 ($14.69 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $14.69.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $14.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.